A phase II trial of adjuvant chemotherapy with weekly paclitaxel (Pac) and carboplatin (Cb) followed by UFT for completely resected pathologic (p-) stage II (N1) and IIIA (N2) non-small cell lung cancer (NSCLC)

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7315-7315
Author(s):  
E. Ogawa ◽  
F. Tanaka ◽  
K. Yanagihara ◽  
H. Wada
Keyword(s):  
Lung Cancer ◽  
Adjuvant Chemotherapy ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Stage Ii ◽  
Weekly Paclitaxel ◽  
Small Cell Lung

Concurrent celecoxib versus placebo in patients with stage II–III non-small cell lung cancer: A randomised phase II trial

2007 ◽  
Vol 84 (1) ◽  
pp. 23-25 ◽  
Author(s):  
Dirk De Ruysscher ◽  
Johan Bussink ◽  
Patrick Rodrigus ◽  
Alfons Kessels ◽  
Miranda Dirx ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Stage Ii ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document